Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.
about
Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidolMouse pharmacological models of cognitive disruption relevant to schizophrenia.Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.Reduced context effects on retrieval in first-episode schizophreniaA virtual reality task based on animal research - spatial learning and memory in patients after the first episode of schizophrenia.Cognitive deficits and cognitive training in schizophrenic patients: a review.Measuring neuropsychological change in schizophrenia with novel antipsychotic medicationsEffect of second-generation antipsychotics on cognition: current issues and future challenges.Neurological soft signs, cognitive dysfunction and ventricular brain ration in schizophrenics.Cognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosisAssessing declarative memory in schizophrenia using Wisconsin Card Sorting Test stimuli: the Paired Associate Recognition Test.Relationship between personality disorder dimensions and verbal memory functioning in a community populationFunctional neuroanatomical correlates of episodic memory impairment in early phase psychosisCognition, schizophrenia, and the atypical antipsychotic drugsComparison of Visuospatial and Verbal Abilities in First Psychotic Episode of Schizophrenia Spectrum Disorder: Impact on Global Functioning and Quality of Life.Psychomotor slowing in schizophreniaToward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.Pupillometric measures of attentional allocation to target and mask processing on the backward masking task in schizophrenia.What do we know about neuropsychological aspects of schizophrenia?Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task.Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.Relationship of neuropsychological and MRI measures to age of onset of schizophrenia.The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders.Reliable change indexes for memory performance in schizophrenia as a means to determine drug-induced cognitive decline.Memory in schizophrenia and affective disorders.
P2860
Q28362116-8B20551D-F9EE-4BF6-8A3E-C1A4BEDC17FFQ30457807-44292633-0145-4BF8-B01F-0A68F6244301Q33238062-70A88E5C-F6CA-4910-9914-4B4442642E46Q33570541-9070ECE6-BD7B-46A5-8B6E-203F0EBA065EQ33668339-07AE1980-9B27-42DA-B91E-2BB5E4542AFEQ33729924-39330B4A-52B5-4161-A378-0F606791846CQ33877837-09B64603-E325-4618-B124-2D6C4FFE071FQ33888153-189C275E-F320-44F7-95C3-843CD10719B3Q34250004-274DF03A-0990-42BA-A89D-048B379D79DBQ34604342-2992FE3E-90BA-41B0-8B18-92A92F2DA8CAQ35095245-800F587D-D996-4259-8F79-FEED0FD2B104Q35957467-8AF4B85C-C186-40A3-A8F9-7E5B92A53ACDQ36032824-15AA6E47-3B2D-49AF-8A1C-581F61A7A0D7Q36086075-633EEB27-3D90-4E33-9226-EE4F31189DE1Q36381682-8FF76EAB-8A80-4B66-9D30-27A628AEFFADQ36648517-9197CE8D-3963-477E-8B36-F6FC427C587FQ36823176-8E7E5D6B-D892-4446-A78F-19E6A5ABA8C9Q37075127-7ACCD767-17B1-412F-9E01-21719A7A9DE6Q37325668-BCC086D0-5EE7-464B-AC09-252DC87EAD78Q37350409-B30C9598-AD42-47F6-90E3-0FC4207B2002Q42470451-80CC4639-6166-44CF-A9F7-C7CD6E64EE57Q45257719-5EDF8FEB-0C60-419F-9C8B-9ECC33D5B372Q46412081-A3DEC4D5-ADE3-4AA7-8FE7-2132C6B6FADBQ47133877-2B96C379-6CAD-4C9E-8DF4-FAEDE9D0677BQ48947559-871554BF-7C60-478A-83B7-DA4EEDDD8923Q52007441-02E80773-197F-4701-9EE4-A7C5D3B0F822Q52054015-B419FF58-8BE0-49A4-876F-4A42BFB86D03
P2860
Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Relation of neuroleptic and an ...... ve functions in schizophrenia.
@en
type
label
Relation of neuroleptic and an ...... ve functions in schizophrenia.
@en
prefLabel
Relation of neuroleptic and an ...... ve functions in schizophrenia.
@en
P1476
Relation of neuroleptic and an ...... ve functions in schizophrenia.
@en
P2093
P304
P356
10.1037//0021-843X.98.4.367
P577
1989-11-01T00:00:00Z